Tata Chemicals Share Price
Sector: Chemical Manufacturing
862.60 -5.60 (-0.65%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
861.00
Today’s High
878.80
52 Week Low
756.45
52 Week High
1244.70
863.10 -5.05 (-0.58%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
861.00
Today’s High
885.00
52 Week Low
756.00
52 Week High
1247.35
Key Metrics
- Market Cap (In Cr) 21975.28
- Beta 1.52
- Div. Yield (%) 1.27
- P/B 1.02
- TTM P/E 108.97
- Peg Ratio -2.06
- Sector P/E 17.07
- D/E 0
- Open Price 877.9
- Prev Close 868.2
Tata Chemicals Analysis
Price Analysis
-
1 Week2.29%
-
3 Months1.6%
-
6 Month-18.02%
-
YTD-17.49%
-
1 Year-19.58%
Risk Meter
- 27% Low risk
- 27% Moderate risk
- 27% Balanced Risk
- 27% High risk
- 27% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 0.00
- 1
- 1
- 1
- Hold
- 1
- 1
- 1
- 1
- Sell
- 5
- 4
- 4
- 4
- Strong Sell
- 1
- 1
- 1
- 1
- Total
- 7
- 7
- 7
- 7
Tata Chemicals News
Q4 results today: Tata Power, Eicher Motors, Lupin, Shree Cements on May 14
1 min read . 14 May 2025Voltas, United Breweries to Tata Chemicals: These five stocks declare dividend
1 min read . 08 May 2025Stocks to watch: Coal India, BSE among shares in focus amid India-Pak conflict
2 min read . 07 May 2025Q4 results today: LTIMindtree, Tata Consumer, Bajaj Housing to declare earnings
2 min read . 23 Apr 2025Tata Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 14887
- Selling/ General/ Admin Expenses Total
- 4725
- Depreciation/ Amortization
- 1123
- Other Operating Expenses Total
- 2910
- Total Operating Expense
- 14182
- Operating Income
- 705
- Net Income Before Taxes
- 521
- Net Income
- 235
- Diluted Normalized EPS
- 11.27
- Period
- 2025
- Total Assets
- 37780
- Total Liabilities
- 16186
- Total Equity
- 21594
- Tangible Book Valueper Share Common Eq
- 424.09
- Period
- 2025
- Cashfrom Operating Activities
- 1761
- Cashfrom Investing Activities
- -1681
- Cashfrom Financing Activities
- 29
- Net Changein Cash
- 123
- Period
- 2024
- Total Revenue
- 15421
- Selling/ General/ Admin Expenses Total
- 5159
- Depreciation/ Amortization
- 979
- Other Operating Expenses Total
- 796
- Total Operating Expense
- 14325
- Operating Income
- 1096
- Net Income Before Taxes
- 830
- Net Income
- 268
- Diluted Normalized EPS
- 29.61
- Period
- 2024
- Total Assets
- 36756
- Total Liabilities
- 14515
- Total Equity
- 22241
- Tangible Book Valueper Share Common Eq
- 456.99
- Period
- 2024
- Cashfrom Operating Activities
- 3016
- Cashfrom Investing Activities
- -610
- Cashfrom Financing Activities
- -2494
- Net Changein Cash
- -83
- Period
- 2023
- Total Revenue
- 16789
- Selling/ General/ Admin Expenses Total
- 4764
- Depreciation/ Amortization
- 890
- Other Operating Expenses Total
- 661
- Total Operating Expense
- 13772
- Operating Income
- 3017
- Net Income Before Taxes
- 2740
- Net Income
- 2317
- Diluted Normalized EPS
- 93.69
- Period
- 2023
- Total Assets
- 35084
- Total Liabilities
- 15363
- Total Equity
- 19721
- Tangible Book Valueper Share Common Eq
- 360.78
- Period
- 2023
- Cashfrom Operating Activities
- 2971
- Cashfrom Investing Activities
- -1186
- Cashfrom Financing Activities
- -2076
- Net Changein Cash
- -254
- Period
- 2022
- Total Revenue
- 12622.12
- Selling/ General/ Admin Expenses Total
- 4024.72
- Depreciation/ Amortization
- 804.92
- Other Operating Expenses Total
- 482.52
- Total Operating Expense
- 11085.09
- Operating Income
- 1537.03
- Net Income Before Taxes
- 1666.63
- Net Income
- 1257.62
- Diluted Normalized EPS
- 50
- Period
- 2022
- Total Assets
- 33843.27
- Total Liabilities
- 15590.38
- Total Equity
- 18252.89
- Tangible Book Valueper Share Common Eq
- 329.14
- Period
- 2022
- Cashfrom Operating Activities
- 1644.33
- Cashfrom Investing Activities
- -836.14
- Cashfrom Financing Activities
- -755.25
- Net Changein Cash
- 72.19
- Period
- 2021
- Total Revenue
- 10199.8
- Selling/ General/ Admin Expenses Total
- 3496.03
- Depreciation/ Amortization
- 758.71
- Other Operating Expenses Total
- 509.78
- Total Operating Expense
- 9388.25
- Operating Income
- 811.55
- Net Income Before Taxes
- 633.99
- Net Income
- 256.37
- Diluted Normalized EPS
- 10.22
- Period
- 2021
- Total Assets
- 28337.2
- Total Liabilities
- 14047.23
- Total Equity
- 14289.97
- Tangible Book Valueper Share Common Eq
- 183.29
- Period
- 2021
- Cashfrom Operating Activities
- 2037.3
- Cashfrom Investing Activities
- -1130.31
- Cashfrom Financing Activities
- -1455.65
- Net Changein Cash
- -564.92
- Period
- 2020
- Total Revenue
- 10356.75
- Selling/ General/ Admin Expenses Total
- 3599.2
- Depreciation/ Amortization
- 665.81
- Other Operating Expenses Total
- 557.54
- Total Operating Expense
- 9035.73
- Operating Income
- 1321.02
- Net Income Before Taxes
- 1248.06
- Net Income
- 7006.33
- Diluted Normalized EPS
- 31.17
- Period
- 2020
- Total Assets
- 27688.75
- Total Liabilities
- 14791.09
- Total Equity
- 12897.66
- Tangible Book Valueper Share Common Eq
- 113.76
- Period
- 2020
- Cashfrom Operating Activities
- 1780.09
- Cashfrom Investing Activities
- -2368.23
- Cashfrom Financing Activities
- -129.26
- Net Changein Cash
- -634.12
- Period
- 2025-03-31
- Total Revenue
- 3509
- Selling/ General/ Admin Expenses Total
- 1219
- Depreciation/ Amortization
- 293
- Other Operating Expenses Total
- 661
- Total Operating Expense
- 3530
- Operating Income
- -21
- Net Income Before Taxes
- -92
- Net Income
- -56
- Diluted Normalized EPS
- -1.5
- Period
- 2025-03-31
- Total Assets
- 37780
- Total Liabilities
- 16186
- Total Equity
- 21594
- Tangible Book Valueper Share Common Eq
- 424.09
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 1761
- Cashfrom Investing Activities
- -1681
- Cashfrom Financing Activities
- 29
- Net Changein Cash
- 123
- Period
- 2024-12-31
- Total Revenue
- 3590
- Selling/ General/ Admin Expenses Total
- 1172
- Depreciation/ Amortization
- 280
- Other Operating Expenses Total
- 780
- Total Operating Expense
- 3506
- Operating Income
- 84
- Net Income Before Taxes
- -4
- Net Income
- -53
- Diluted Normalized EPS
- -0.29
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 3999
- Selling/ General/ Admin Expenses Total
- 1190
- Depreciation/ Amortization
- 277
- Other Operating Expenses Total
- 743
- Total Operating Expense
- 3658
- Operating Income
- 341
- Net Income Before Taxes
- 348
- Net Income
- 194
- Diluted Normalized EPS
- 7.61
- Period
- 2024-09-30
- Total Assets
- 37621
- Total Liabilities
- 15426
- Total Equity
- 22195
- Tangible Book Valueper Share Common Eq
- 453.49
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 673
- Cashfrom Investing Activities
- -564
- Cashfrom Financing Activities
- -91
- Net Changein Cash
- 25
- Period
- 2024-06-30
- Total Revenue
- 3789
- Selling/ General/ Admin Expenses Total
- 1144
- Depreciation/ Amortization
- 273
- Other Operating Expenses Total
- 726
- Total Operating Expense
- 3488
- Operating Income
- 301
- Net Income Before Taxes
- 269
- Net Income
- 150
- Diluted Normalized EPS
- 5.3
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 3475
- Selling/ General/ Admin Expenses Total
- 1139
- Depreciation/ Amortization
- 271
- Other Operating Expenses Total
- 783
- Total Operating Expense
- 4266
- Operating Income
- -791
- Net Income Before Taxes
- -796
- Net Income
- -850
- Diluted Normalized EPS
- -7.89
- Period
- 2024-03-31
- Total Assets
- 36756
- Total Liabilities
- 14515
- Total Equity
- 22241
- Tangible Book Valueper Share Common Eq
- 456.99
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 3016
- Cashfrom Investing Activities
- -610
- Cashfrom Financing Activities
- -2494
- Net Changein Cash
- -83
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Tata Chemicals Technical
Moving Average
SMA
- 5 Day847.11
- 10 Day834.86
- 20 Day840.94
- 50 Day830.91
- 100 Day893.06
- 300 Day989.25
Tata Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Himadri Speciality Chemical
- 462.65
- 0
- 0
- 688.5
- 307.3
- 22840.16
- Bayer Cropscience
- 5100
- 23
- 0.45
- 7189.9
- 4220.05
- 22982.35
- Tata Chemicals
- 862.6
- -5.6
- -0.65
- 1244.7
- 756.45
- 21975.28
- Kansai Nerolac Paints
- 262.4
- -1.65
- -0.62
- 320.65
- 218.35
- 21238.97
- Navin Fluorine International
- 4324
- 15.1
- 0.35
- 4774.85
- 2876.45
- 21541.23
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Himadri Speciality Chemical
- 41.02
- 6.13
- 10.85
- 7.27
- Bayer Cropscience
- 29.91
- 7.95
- 24.11
- 13.62
- Tata Chemicals
- 76.27
- 1.01
- 4.72
- 7.28
- Kansai Nerolac Paints
- 18.24
- 3.32
- 15.78
- 10.47
- Navin Fluorine International
- 72.96
- 8.01
- 14.45
- 15.83
Tata Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-May-25
- Audited Results, Final Dividend & Others
- 03-Feb-25
- Quarterly Results
- 17-Oct-24
- Quarterly Results
- 05-Aug-24
- Quarterly Results
- 29-Apr-24
- Audited Results, Dividend & Others
- 05-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 03-May-23
- Audited Results & Final Dividend
- 01-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 26-Jun-24
- 21-May-24
- AGM
- 26-Jun-23
- 16-May-23
- AGM
- 25-Mar-23
- 21-Feb-23
- POM
- 06-Jul-22
- 29-Apr-22
- AGM
- 02-Jul-21
- 03-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 07-May-25
- 12-Jun-25
- 12-Jun-25
- 11
- 29-Apr-24
- 12-Jun-24
- 12-Jun-24
- 15
- 03-May-23
- -
- 14-Jun-23
- 17.5
- 29-Apr-22
- -
- 15-Jun-22
- 12.5
- 03-May-21
- -
- 14-Jun-21
- 10


